rituximab,ibrutinib,Bendamustine
biogen,roche,novartis,janssen,abbvie
['lymsm', 'shine']
shine #asco22 #lymsm 1l mcl in &gt;=65y
br-&gt;r vs ibrutinibbr-&gt;ir
n 523 fu 7.1 y
pfs 52.9 vs 80.6 mo hr 0.75
p53 mutation pfs higher but not ss
mos not reached and curves superimposed. my take: not ready for clinic yet
ibr no longer preferred btki
benefit of concurrent vs seq ibr? 
Clinician-researcher-educator bookworm @RoswellPark. Passionate about #Lymphoma #CLL #GeriOnc #PRO #MedEd Proud alum @OfficialJipmer @AIIMS_ND @UpstateNews